Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05653882 |
|---|---|
| Brief Title: | A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors |
| First Submitted : | November 30, 2022 |
| First Submitted that Met QC Criteria : | December 8, 2022 |
| First Posted : | December 16, 2022 |
| Last Update Submitted that Met QC Criteria : | May 9, 2024 |
| Last Update Posted : | May 13, 2024 |